FDA Approves Expanded Age Indication for Nerivio Migraine Device in Pediatric Patients
"The FDA approved Nerivio for treating acute migraines in patients aged 8 and older, marking a first in non-drug pediatric migraine therapy."
#MigraineChat
The risk of clade I mpox to the public remains low.
Comforting since we could have Captain Brain Worms at the helm soon.
🙄
The risk of clade I mpox to the public remains low.
Comforting since we could have Captain Brain Worms at the helm soon.
🙄